
About PerkinElmer
PerkinElmer is a company based in Waltham (United States) founded in 1931. The company has 219 employees. PerkinElmer has completed 35 acquisitions, including ArtusLabs, BioLegend and Caliper Life Sciences. PerkinElmer operates in a competitive market with competitors including Cytiva, Labviva, Zageno, Fortis Life Sciences and Leica Biosystems, among others.
- Headquarter Waltham, United States
- Employees 219
- SectorsHealthcare
- Website perkinelmer.com
- Social LinkedIn X
- Net Profit$727.89 M (USD)220as on Dec 31, 2020
- EBITDA$978.58 M (USD)170as on Dec 31, 2020
- Latest Funding Round$500M (USD), Debt – Conventional
Aug 2021
- Investors
- Employee Count219
- Investments & AcquisitionsArtusLabs
& 34 more
Associated legal entities of PerkinElmer
PerkinElmer is associated with 3 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Revvity Healthcare (India) Private Limited CIN U74999MH2004PTC145744 | Active | 16 Apr 2004 | Thane, Maharashtra | ₹238 Cr | – | 4 | View details |
| Revvity Health Sciences Private Limited CIN U85100TN2009PTC072319 | Active | 20 Jul 2009 | Chennai, Tamil Nadu | ₹38.2 Cr | 90 | 5 | View details |
| Tulip Diagnostics Private Limited CIN U85195GA1988PTC005717 | Active | 14 Dec 1988 | Tiswadi, Goa | ₹553 Cr | 1,416 | 3 | View details |
Funding Insights of PerkinElmer
- Total Rounds 21
- Last Round Debt – Conventional β $500M
- Investors Count 1
Latest 10 of 21 funding rounds of PerkinElmer with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2021 | $500M | Debt – Conventional | β | β | β |
| Feb 2021 | $21,663 | Grant | β | β | |
| Nov 2020 | $185,448 | Grant | β | β | |
| Nov 2020 | $63,073 | Grant | β | β | |
| Dec 2019 | $145,574 | Grant | β | β | |
| Nov 2019 | $166,543 | Grant | β | β | |
| Sep 2019 | $850M | Debt – Conventional | β | β | β |
| Sep 2019 | $1B | Debt – Conventional | β | β | β |
| Feb 2019 | $20,214 | Grant | β | β | |
| Dec 2018 | $160,738 | Grant | β | β |
1 investors in total: 1 institutional.
Investors in PerkinElmer
PerkinElmer has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for PerkinElmer
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of PerkinElmer
The boards of the 3 registered companies of PerkinElmer currently have 8 directors; the longest-serving is Seshadri Suresh, appointed in 2009. 29 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Seshadri Suresh DIN 00136404 | Director | 04 Sep 2009 | 17 yrs 1 mo | Revvity Health Sciences Private Limited |
| John Leo Healy DIN 02819115 | Director | 15 Dec 2009 | 16 yrs 9 mo | Revvity Health Sciences Private Limited |
| Alok Kumar DIN 05119699 | Director | 16 Nov 2011 | 14 yrs 10 mo | Revvity Healthcare (India) Private Limited, Revvity Health Sciences Private Limited, Tulip Diagnostics Private Limited |
| Jayashree Kailas Thacker DIN 07105039 | Director | 17 Mar 2015 | 11 yrs 6 mo | Revvity Healthcare (India) Private Limited, Revvity Health Sciences Private Limited |
| Deepak Gurushankar Tripathi DIN 02021472 | Director | 05 May 2017 | 9 yrs 5 mo | Tulip Diagnostics Private Limited |
| Narendra Makkar DIN 07940889 | Director | 19 Sep 2017 | 9 yrs | Tulip Diagnostics Private Limited |
| Shripad Digamber Rao Joshi DIN 08825256 | Director | 07 Aug 2020 | 6 yrs 2 mo | Revvity Healthcare (India) Private Limited |
| Ajita Rahul Pansare DIN 11027887 | Additional Director | 01 Apr 2025 | 1 yr 6 mo | Revvity Healthcare (India) Private Limited, Revvity Health Sciences Private Limited |
People of PerkinElmer
337 people are tracked at PerkinElmer (73 in leadership, 9 in board & advisors, 255 in team); the tracked headcount is 219.
| Name | Role | Group |
|---|---|---|
Prahlad Singh | CEO | Leadership |
Kris Leong | Japan GM And Country President | Leadership |
Alexey Sosnovskiy | Chief Of Staff | Head Of Value Creation Office | Leadership |
Dana Schaaf | Talent Acquisition Partner | Leadership |
Erica Johnson | Senior Talent Acquisition Partner | Leadership |
John Kavanagh | Head Of Infrastructure & Operations | Leadership |
Dian Chen | VP Of Product Portfolio | Leadership |
Johan Lundin | Vice President Special Projects | Leadership |
Geoffray Colson | Vice President Global Quality | Leadership |
Joe Roach | Chief Technology Officer | Leadership |
Rosemary Pitts | Chief Financial Officer | Leadership |
Kris Keegan | Vice President, General Counsel, Discovery & Analytical Solutions | Leadership |
Jim Plassard | Scientific Services General Manager, Onesource | Leadership |
Brian Holbrook | Director Global Indirect Procurement | Leadership |
Dale Durham | Sr. Director, Global Services, Technical Support And Training | Leadership |
Walter Faraci | General Manager - Onesource Enterprise | Leadership |
Robert Hannagan | Director Of Operations | Leadership |
Gracie Chen | HR Director, DAS APAC | Leadership |
Guido Lerch | Sr. Director, Quality & Compliance | Cloud Governance - Informatics | Leadership |
Scott Greenwood | General Manager - Onesource | Leadership |
317 more people are available in the full profile.
Complete people profiles for PerkinElmer
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of PerkinElmer
Figures of Revvity Healthcare (India) Private Limited, the primary company behind PerkinElmer, for FY 2025. Revenue was ₹238 Cr (+3% year on year). Net profit was ₹6.83 Cr (3% margin). EBITDA was ₹21.44 Cr (9% margin). Revenue has grown at a compounded annual rate of +40% over three years and +1% over five years.
- ₹238 CrRevenue · FY 2025 · +3% YoY
- ₹6.83 CrNet profit · 3% margin
- ₹21.44 CrEBITDA · 9% margin
- ₹4.28 CrPaid-up capital
- +40%Revenue CAGR, 3 years
- +1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Revvity Healthcare (India) Private Limited are on its company page.
Detailed financial statements for PerkinElmer
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PerkinElmer
PerkinElmer has strategically engaged in corporate development activities, having acquired 35 companies. Notable acquisitions include ArtusLabs, BioLegend and Caliper Life Sciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of consulting, quality, regulatory, and marketing services to biopharma sector | projectfarma.com | Bethesda, United States | 2013 | Mar 2025 | β’β’β’β’ | |
Sample preparation platforms using ultrasonic acoustics | covaris.com | Woburn, United States | 1998 | Dec 2023 | β’β’β’β’ | |
Preclinical ultrasonic imaging of tissue and vasculature is provided. | sonovol.com | Durham, United States | 2012 | Feb 2022 | β’β’β’β’ | |
Immunological reagents are developed and manufactured for biomedical research. | biolegend.com | San Diego, United States | 2002 | Jul 2021 | $5.25B | |
Customized AAV-based viral vectors for gene therapy are supplied. | sirion-biotech.com | Planegg, Germany | 2005 | Jun 2021 | β’β’β’β’ | |
Immunoassays and automated analyzers for endocrinology are developed and marketed. | idsplc.com | East Boldon, United Kingdom | 1977 | May 2021 | $155M | |
Automated cell counting and imaging solutions are developed for cytometry. | nexcelom.com | Lawrence, United States | 2003 | May 2021 | $260M | |
Developer of high performance bonded phases and packing materials for HPLC and SFC | esind.com | West Berlin, United States | 1962 | Mar 2021 | β’β’β’β’ | |
Immune markers are utilized by Oxford Immunotec for disease diagnostics. | oxfordimmunotec.com | Abingdon, United Kingdom | 2002 | Jan 2021 | $591M | |
Genetically modified cell lines are developed using AAV gene-editing platform. | horizondiscovery.com | Cambridge, United Kingdom | 2007 | Nov 2020 | $383M |
Complete acquisition details for PerkinElmer
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PerkinElmer
13 dated milestones of PerkinElmer across 94 years, from founding to its latest funding, stage changes and deals.
- Founded PerkinElmer is founded.
- Funding First funding round.
- Acquisition Acquires Horizon Discovery.
- Acquisition Acquires Oxford Immunotec.
- Acquisition Acquires ES Industries.
- Acquisition Acquires Nexcelom Bioscience.
- Acquisition Acquires Immunodiagnostic Systems.
- Acquisition Acquires Sirion Biotech.
- Acquisition Acquires BioLegend.
- Funding Latest funding round, Debt β Conventional, of $500.0M.
- Acquisition Acquires SonoVol.
- Acquisition Acquires Covaris.
- Acquisition Acquires Project Farma.
Competitors of PerkinElmer
PerkinElmer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytiva, Labviva, Zageno, Fortis Life Sciences and Leica Biosystems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cytivalifesciences.com | 1968 | Sheffield, United Kingdom | – | 578 | Life science software and research products are provided online. | |
| labviva.com | 2017 | Cambridge, United States | $55.75M | 8 | An AI-powered marketplace for life science products is operated. | |
| zageno.com | 2015 | Cambridge, United States | $120.93M | 51 | Marketplace and life science research community for biotech research kits | |
| fortislife.com | 2020 | Waltham, United States | – | – | A trusted partner in life sciences and diagnostics solutions. | |
| leicabiosystems.com | 1989 | Nussloch, Germany | – | 365 | Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide. | |
| meenta.io | 2016 | Boston, United States | $2.47M | – | Operates a digital marketplace for sequencing instruments. | |
| celltreat.com | 2008 | Pepperell, United States | – | – | Produces laboratory plastic consumables like pipets and vials for efficient scientific research. |
Detailed competitors of PerkinElmer
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PerkinElmer
The website of PerkinElmer (perkinelmer.com) receives about 164.5K visits a month.
- Monthly visits164.5K
▼ 4.5% vs previous month
Websites whose visitors overlap most with PerkinElmer. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cambridgesoft.com | 100% | – | – | View details | |
| tainstruments.com | 99% | – | #320,048 | View details | |
| waters.com | 92% | 416.8K | #124,184 | View details | |
| shimadzu.com | 90% | 271K | #178,629 | View details | |
chem.agilent.com | chem.agilent.com | 81% | – | – | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for PerkinElmer
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Perkinelmer
Complete news archive for PerkinElmer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to PerkinElmer
10 companies that operate in the same segment as PerkinElmer (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PerkinElmer
PerkinElmer was founded in 1931 and raised its 1st funding round 83 years after it was founded.
PerkinElmer is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Prahlad Singh is the current CEO of PerkinElmer.
PerkinElmer has 219 employees.
Provider and manufacturer of medical instruments and supplies for the healthcare industry. The company has an online selling platform for medical instruments such as medical imaging, atomic spectroscopy, automation liquid handling, cell harvesters, chromatography, cytogenetics, content screening, hyphenated technology devices, and more. In 2022, the company recorded annual revenues of 3.94B and a net profit of 0.56B.
PerkinElmer has made 35 acquisitions, including ArtusLabs, BioLegend, and Caliper Life Sciences.
PerkinElmer has 1 investor. Key investors include European Union.
PerkinElmer is associated with 3 legal entities: Revvity Healthcare (India) Private Limited, Revvity Health Sciences Private Limited, Tulip Diagnostics Private Limited.
The legal entities of PerkinElmer currently have 8 directors, including Shripad Digamber Rao Joshi, Alok Kumar, Jayashree Kailas Thacker and others.
The website of PerkinElmer receives about 165 thousand visits a month.
